[1]
Nicolini, A.; Barak, V.; Biava, P.; Ferrari, P.; Rossi, G.; Carpi, A. The use of immunotherapy to treat metastatic breast cancer. Curr. Med. Chem., 2019, 26(6), 941-962.
[2]
Ferrari, S.M.; Centanni, M.; Virili, C.; Miccoli, M.; Ferrari, P.; Ruffilli, I.; Ragusa, F.; Antonelli, A.; Fallahi, P. Sunitinib in the treatment of thyroid cancer. Curr. Med. Chem., 2019, 26(6), 963-972.
[3]
Albini, A.; Bassani, B.; Baci, D.; Dallaglio, K.; Gallazzi, M.; Corradino, P.; Bruno, A.; Noonan, D.M. Nutraceuticals and “repurposed” drugs of phytochemical origin in prevention and interception of chronic degenerative diseases and cancer. Curr. Med. Chem., 2019, 26(6), 973-987.
[4]
Biava, P.M.; Burigana, F.; Germano, R.; Kurian, P.; Verzegnassi, C.; Vitiello, G. Stem cell differentiation stage factors and their role in triggering symmetry breaking processes during cancer development: A quantum field theory model for reprogramming cancer cells to healthy phenotypes. Curr. Med. Chem., 2019, 26(6), 988-1001.
[5]
Klener, P., Jr; Etrych, T.; Klener, P. Biological therapy of hematologic malignancies: Toward a chemotherapy- free era. Curr. Med. Chem., 2019, 26(6), 1002-1018.
[6]
Pavelka, K.; Jarosova, H.; Sleglova, O.; Svobodova, R.; Votavova, M.; Milani, L.; Prochazka, Z.; Kotlarova, L.; Kostiuk, P.; Sliva, J.; Meroni, A.M. Chronic low back pain: Current pharmacotherapeutic therapies and a new biological approach. Curr. Med. Chem., 2019, 26(6), 1019-1026.
[7]
Freer, G.; Maggi, F.; Pistello, M. Virome and inflammasomes, a finely tuned balance with important consequences for the host health. Curr. Med. Chem., 2019, 26(6), 1027-1044.
[8]
Anceschi, U.; Tuderti, G.; Lugnani, F.; Biava, P.M.; Malossini, G.; Luciani, L.; Cai, T.; Marsiliani, D.; Filianoti, A.; Mattevi, D.; Costantini, M.; Misuraca, L.; Simone, G. Novel diagnostic biomarkers of prostate cancer: An update. Curr. Med. Chem., 2019, 26(6), 1045-1058.
